vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and SES AI Corp (SES). Click either name above to swap in a different company.

SES AI Corp is the larger business by last-quarter revenue ($4.6M vs $4.1M, roughly 1.1× Spectral AI, Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -373.5%, a 399.2% gap on every dollar of revenue.

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

SES S.A. is a Luxembourgish communications satellite operator supplying video and data connectivity worldwide to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions.

MDAI vs SES — Head-to-Head

Bigger by revenue
SES
SES
1.1× larger
SES
$4.6M
$4.1M
MDAI
Higher net margin
MDAI
MDAI
399.2% more per $
MDAI
25.7%
-373.5%
SES

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDAI
MDAI
SES
SES
Revenue
$4.1M
$4.6M
Net Profit
$1.1M
$-17.0M
Gross Margin
45.2%
11.3%
Operating Margin
-54.9%
-387.7%
Net Margin
25.7%
-373.5%
Revenue YoY
-46.3%
Net Profit YoY
113.9%
50.7%
EPS (diluted)
$0.04
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
SES
SES
Q4 25
$4.1M
$4.6M
Q3 25
$3.8M
$7.1M
Q2 25
$5.1M
$3.5M
Q1 25
$6.7M
$5.8M
Q4 24
$7.6M
Q3 24
$8.2M
Q2 24
$7.5M
Q1 24
$6.3M
Net Profit
MDAI
MDAI
SES
SES
Q4 25
$1.1M
$-17.0M
Q3 25
$-3.6M
$-20.9M
Q2 25
$-8.0M
$-22.7M
Q1 25
$2.9M
$-12.4M
Q4 24
$-7.6M
Q3 24
$-1.5M
Q2 24
$-2.9M
Q1 24
$-3.2M
Gross Margin
MDAI
MDAI
SES
SES
Q4 25
45.2%
11.3%
Q3 25
42.7%
51.1%
Q2 25
45.2%
73.7%
Q1 25
47.2%
78.7%
Q4 24
44.0%
Q3 24
44.9%
Q2 24
44.3%
Q1 24
46.6%
Operating Margin
MDAI
MDAI
SES
SES
Q4 25
-54.9%
-387.7%
Q3 25
-88.1%
-262.0%
Q2 25
-41.9%
-652.3%
Q1 25
-13.4%
-401.7%
Q4 24
-14.6%
Q3 24
-10.8%
Q2 24
-32.7%
Q1 24
-33.9%
Net Margin
MDAI
MDAI
SES
SES
Q4 25
25.7%
-373.5%
Q3 25
-93.7%
-293.9%
Q2 25
-157.3%
-642.2%
Q1 25
43.2%
-214.6%
Q4 24
-99.8%
Q3 24
-18.4%
Q2 24
-38.3%
Q1 24
-50.7%
EPS (diluted)
MDAI
MDAI
SES
SES
Q4 25
$0.04
$-0.05
Q3 25
$-0.13
$-0.06
Q2 25
$-0.31
$-0.07
Q1 25
$0.11
$-0.04
Q4 24
$-0.42
Q3 24
$-0.08
Q2 24
$-0.16
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
SES
SES
Cash + ST InvestmentsLiquidity on hand
$15.4M
$29.5M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$214.8M
Total Assets
$21.4M
$272.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
SES
SES
Q4 25
$15.4M
$29.5M
Q3 25
$10.5M
$35.3M
Q2 25
$10.5M
$11.8M
Q1 25
$14.1M
$56.1M
Q4 24
$5.2M
Q3 24
$3.7M
Q2 24
$6.9M
Q1 24
$10.2M
Total Debt
MDAI
MDAI
SES
SES
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
SES
SES
Q4 25
$-5.7M
$214.8M
Q3 25
$-8.2M
$228.2M
Q2 25
$-9.2M
$249.2M
Q1 25
$-1.6M
$269.9M
Q4 24
$-7.3M
Q3 24
$-4.8M
Q2 24
$-4.7M
Q1 24
$-2.5M
Total Assets
MDAI
MDAI
SES
SES
Q4 25
$21.4M
$272.6M
Q3 25
$15.3M
$288.8M
Q2 25
$16.0M
$290.5M
Q1 25
$20.7M
$306.0M
Q4 24
$12.1M
Q3 24
$11.6M
Q2 24
$13.9M
Q1 24
$15.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
SES
SES
Operating Cash FlowLast quarter
$-2.6M
$-10.4M
Free Cash FlowOCF − Capex
$-11.1M
FCF MarginFCF / Revenue
-243.7%
Capex IntensityCapex / Revenue
15.6%
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters
$-61.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
SES
SES
Q4 25
$-2.6M
$-10.4M
Q3 25
$-2.5M
$-14.3M
Q2 25
$-3.4M
$-10.8M
Q1 25
$-1.5M
$-22.8M
Q4 24
$469.0K
Q3 24
$-1.6M
Q2 24
$-5.4M
Q1 24
$-2.7M
Free Cash Flow
MDAI
MDAI
SES
SES
Q4 25
$-11.1M
Q3 25
$-14.7M
Q2 25
$-11.6M
Q1 25
$-23.7M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MDAI
MDAI
SES
SES
Q4 25
-243.7%
Q3 25
-206.9%
Q2 25
-329.6%
Q1 25
-410.0%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MDAI
MDAI
SES
SES
Q4 25
15.6%
Q3 25
6.0%
Q2 25
22.8%
Q1 25
15.8%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MDAI
MDAI
SES
SES
Q4 25
-2.43×
Q3 25
Q2 25
Q1 25
-0.52×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons